Cannabis has long carried the reputation of a balm for modern anxiety, yet a study from Oregon State University quietly challenges that assumption. Researchers tracking cortisol levels in regular users found that those who reach for cannabis most often wake each morning with their stress systems already running higher than those who abstain — a finding that asks us to reconsider what relief and dependency truly look like in the body. The science remains incomplete, but the question it raises is ancient: do we sometimes seek comfort in the very thing that quietly sustains our discomfort?
Regular Cannabis Use Linked to Higher Morning Cortisol Levels, Study Finds
Cobertura Relacionada
NHMRC is investing nearly one million dollars to enable Australian researchers to collaborate on international health pr…
Citizen Digital · Jul 29 Zimbabwe's new 210-million-year-old dinosaur reveals diverse ancient ecosystemsScientists identified a 210-million-year-old dinosaur species in Zimbabwe, suggesting southern Africa hosted distinct ec…
starlust.org · Jul 29 NASA's CAPSTONE 02 to test dual-satellite docking for Artemis lunar missionsNASA's CAPSTONE 02 mission, launching in 2027, will test spacecraft docking and autonomous navigation in lunar orbit usi…
news.cgtn.com · Jul 29 Chinese astronomers discover pulsar with three simultaneous emission variationsChinese researchers identified a pulsar simultaneously exhibiting three emission variability phenomena—nulling, mode swi…
Impacto Geopolítico
This is a health/medical research article with no geopolitical implications; it reports on cannabis' physiological effects on stress hormones, not international relations.
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Lente Econômica
Study reveals regular cannabis use correlates with elevated morning cortisol levels, contradicting stress-relief perception and potentially signaling health risks that could reshape consumer demand and healthcare costs.
Regular cannabis users may face increased healthcare costs, workplace productivity concerns, and potential insurance premium adjustments if findings are validated. Consumer perception of cannabis as stress-relief may shift, reducing demand among health-conscious users and those self-medicating for anxiety.
Findings could prompt regulatory agencies to strengthen cannabis labeling warnings about stress/cortisol effects, influence workplace drug policies, and potentially trigger insurance coverage restrictions. May accelerate medical research funding and clinical guidelines around cannabis use, particularly for mental health claims.